The season for networking and meeting existing and potential partners is in full swing. Will you be attending #BIO2024 in San Diego? We'd love to connect with you! Reach out to Selen Kafadar and Reyk Horland here or through the BIO partnering system. Let’s collaborate and advance our drug development to the next level.
TissUse GmbH’s Post
More Relevant Posts
-
#Biotechs, the road to getting a drug to the clinic can be filled with speed bumps.. This webinar provides guidance to navigate these roadblocks. https://okt.to/VmB1Fc #drugdevelopment
To view or add a comment, sign in
-
Please join us for our last webinar in the biotech series around optimizing launch -- should make for a fascinating discussion!
Last chance to join our exclusive webinar series tailored for commercial and market access biotech professionals. Make sure to save your seat today to get insights! skp.link/2fz #BiotechWebinar #BiotechnologyIndustry #MarketAccess #SKEvent #SimonKucher #BetterGrowth
To view or add a comment, sign in
-
#VeevaSummit is quickly approaching! Sarah Caldwell, general manager, Veeva Crossix, shares her thoughts on what she’s looking forward to the most. Let us know what you’re most excited about and register in the comments below. 👇 #biotechnology
The countdown to #VeevaSummit is on. We’re heading back to Boston May 7 - 8, and I’m thrilled to share some of the things I’m most looking forward to this time around: 1. Reconnecting with friends and colleagues 2. Sharing insights to navigate today’s media landscape 3. Taking a walk around Boston Common and the Public Garden What are you looking forward to at Summit? Let me know in the comments. Take a look at the Veeva Crossix Zone agenda to see what we have planned: https://bit.ly/3Vi3KQN #VeevaSummit #biotechnology #pharmamarketing
To view or add a comment, sign in
-
-
The first Bio on the Bay event in 2009 might have solidified our mission (https://hubs.li/Q021WLYp0), but the next few events in solidified our why. Our meetups were creating more than just an opportunity and a space for candidates and employers to meet. In an industry built on trust, our events were creating a trusted space for conversations and a connected community. So, as we get ready to celebrate 14 years of impact and 5 years of BioBuzz-ing, 🎉 help us celebrate our history. Share a memory, share a story, share a photo, share your BioBuzz 𝒘𝙝𝒚. https://hubs.li/Q021WLpQ0 #lifesciences #biotech #pharma #biobuzz
To view or add a comment, sign in
-
-
Last chance to join our exclusive webinar series tailored for commercial and market access biotech professionals. Make sure to save your seat today to get insights! skp.link/2fz #BiotechWebinar #BiotechnologyIndustry #MarketAccess #SKEvent #SimonKucher #BetterGrowth
To view or add a comment, sign in
-
Are you attending BIO Investor Forum 2023, this month? Book a meeting with our Director, Paul Cronin, by Searching 'Scendea' in the partnering platform or get in touch [email protected] - #Partnering #DrugDevelopment #RegulatoryAffairs #BiotechEvents
To view or add a comment, sign in
-
-
📷 Are you attending Swiss Biotech Day? Connect with our delegates to start a conversation and discover how we can assist you with our agile and holistic biotech solutions! #biotech #swissbiotechday2024 Swiss Biotech Association
To view or add a comment, sign in
-
-
Getting ready for tomorrow! See you at BioTechX, booth #112, where you will find the #GenedataProfiler team for the next three days. Ah ... and yes, we have a coffee machine. Jump by for a good coffee and a nice chat about #PrecisionMedicine ;) #PathToPrecision #TranslationalResearch #DigitalizingBiopharma #DataScience #BioTechXEU #BiotechX
To view or add a comment, sign in
-
-
Exciting developments in drug discovery! The recent update to AlphaFold, now AlphaFold3, represents a significant leap forward in protein structure prediction. This breakthrough, highlighted in a May 8, 2024, Nature publication, brings new capabilities for modeling interactions between proteins and various molecules—a major win for drug discovery. However, DeepMind's restriction of AlphaFold3 to non-commercial use limits its potential impact. Read the blog to see where xBxBio steps in. 🔗 Read the blog post here #DrugDiscovery #Biotech #Innovation #Healthcare #Pharmaceuticals #xBxBio https://wix.to/DRDDv4p
Blog | xBxBio
xbxbio.com
To view or add a comment, sign in
More from this author
-
New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis
TissUse GmbH 1y -
Dr. Uwe Marx is being honored with the Russell and Burch Award
TissUse GmbH 2y -
Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract
TissUse GmbH 3y